People are definitely being dosed with BCG right now.

Where there might be confusion is due to the information that was
recently published regarding preclinical work that was done on
blood samples over the last few years, which provided a "proof of
concept" that this protocol, which was successful in mice, also works
in the blood of humans, and not just mice.

The trial now is administering BCG to people, and gathering data to
see if the drug is safe (which everyone expects it to be since it has
such a long record of being safe - 80+ years of usage worldwide), and
also to collect data of any changes to the levels of autoimmunity
(defective T-cells) and other indicators (e.g. C-peptide, etc.) in
the blood in the trial participants to see if there's any changes
that might point to a corrective process. They are using the blood
assay equipment that was developed to check the number of defective t-
cells and see if they are reducing.

Hope this really quick answer helps clarify.

Thanks,
Stacy Lavery


--- In nathanfaustmantrials@yahoogroups.com, "Carla"
<shortmuffin79@...> wrote:

> Some people are confused about whether humans are acutally being
> given BCG right now, or if only their blood is being used. Can
> someone clarify?
>
> --- In nathanfaustmantrials@yahoogroups.com, Lorraine Sisto
> <lsisto1@> wrote:
> >
> > Thank you so much for the inside info!
> >
> > View for Caleb to win the OmniPod contest - watch his video:
> > http://www.youtube.com/watch?v=9chqqZPYL40
> >
> > Lorraine Sisto
> > lsisto1@
> >
> >
> >
> >
> >
> > On Dec 13, 2008, at 9:18 AM, Nancy Parr wrote:
> >
> > > Hello Stacy,
> > >
> > > Just an FYI for the group. I called the Faustman Lab this week
> and
> > > had an
> > > excellent chat with Melissa and also with Lynn Murphy. I
> provided
> > > Lynn
> > > with a copy of the list of the Iacocca Foundation State
Captains
> and
> > > their
> > > email addresses so that we all could get in their data base and
> start
> > > receiving future newsletters.
> > >
> > > I am working with them to set up a memorial fund for my
mother.
> She
> > > is
> > > very, very sick, but still holding on. Her wishes have been to
> have
> > > memorial contibutions sent to the Iacocca Foundation, which
she
> > > knows I
> > > have supported for the last few years. We are making sure now
> that
> > > these
> > > contributions get directly to the Faustman Lab in her memory.
> > >
> > > One blessing that has come of all of this, is that I have had
> this
> > > chance
> > > to talk directly with the people at the Faustman Lab. I was
very
> > > encouraged to hear Melissa talk about all of their work. She
> was even
> > > telling me that they were trying to convince the FDA to include
> a
> > > pediatric
> > > trial in Phase II. If this were to come to fruition, my
> daughter
> > > would be
> > > very excited to participate.
> > >
> > > Peace to all this season,
> > > Nancy Parr
> > >
> > >> [Original Message]
> > >> From: Stacy Lavery <stacy_lavery@>
> > >> To: NathanFaustman YahooGroup
> <nathanfaustmantrials@yahoogroups.com>
> > >> Date: 12/9/2008 4:29:16 PM
> > >> Subject: [nathanfaustmantrials] Newsletter update from the
> Faustman
> > >> lab
> > >>
> > >>
> > >>
> > >>
> > >>
> > >> ----- Forwarded Message ----
> > >> From: MGH Diabetes Clinical Trial <DiabetesTrial@>
> > >> To: Stacy_Lavery@
> > >> Sent: Tuesday, December 9, 2008 12:24:01 PM
> > >> Subject: Newsletter update from the Faustman lab
> > >>
> > >>
> > >> MASSACHUSETTS GENERAL HOSPITAL
> > >> Immunobiology Laboratory
> Denise
> > > Faustman, MD., Ph.D.
> > >> Massachusetts General Hospital East
> Director,
> > > Immunobiology Laboratory
> > >> Building 149, Thirteenth Street, Room 3601
> Associate
> > >> Professor
> > > of Medicine
> > >> Charlestown, Massachusetts 02129
> Harvard
> > >> Medical
> > > School
> > >> Tel: 617-726-4084
> > >> Fax: 617-726-4095
> > >>
> > >>
> > >> December 8, 2008
> > >>
> > >> Dear Friends,
> > >>
> > >> It has been a tremendous year for us here at the MGH
> Immunobiology
> > > Laboratory in Boston.
> > >>
> > >>
> > >> We have seen the benefits of our hard work in the successful
> launch
> > >> of
> > >> our Phase I clinical trial, the publication of our research in
> the
> > >> Proceedings of the National Academy of Sciences, and the
> ongoing
> > >> response
> > >> to our efforts to raise diabetes awareness.
> > >>
> > >> Attached you will find our latest newsletter detailing these
> > > accomplishments and more.
> > >> Thank you for your continuous support in our efforts. It is
> with
> > >> your
> > > dedication to this
> > >> cause that we can move towards helping more people with
> diabetes.
> > >>
> > >> Happy Holidays,
> > >>
> > >>
> > >>
> > >> Denise Faustman, MD., Ph.D.
> > >>
> > >> Please visit our website: www.faustmanlab.org
> > >>
> > >>
> > >> The information in this e-mail is intended only for the person
> to
> > >> whom it
> > > is
> > >> addressed. If you believe this e-mail was sent to you in error
> and
> > >> the
> > > e-mail
> > >> contains patient information, please contact the Partners
> Compliance
> > > HelpLine at
> > >> http://www.partners.org/complianceline . If the e-mail was
sent
> to
> > >> you in
> > > error
> > >> but does not contain patient information, please contact the
> sender
> > >> and
> > > properly
> > >> dispose of the e-mail.
> > >>
> > >>
> > >>
> > >>
> > >
> > >
> > >
> > > ------------------------------------
> > >
> > > Yahoo! Groups Links
> > >
> > >
> > >
> >
>